Bacil Pharma Board Meeting on Director Appointment

Bacil Pharma Limited has submitted a regulatory intimation to BSE Limited. The purpose of the disclosure is to inform the exchange of an upcoming meeting of the Board of Directors.

The Board meeting is scheduled to be held on Tuesday, 25th August, 2026. The agenda for the meeting includes two key items:

1. Discussion on Appointment of Directors.

2. Any other business with the permission of the Chairperson.

The communication was digitally signed by Ms. Chaitali Kalpataru Shah, who holds the positions of Director & CFO. Her DIN is 11167778. The company requested the exchange to take the intimation on record and acknowledge its receipt.

Financial impact, operational details, or specific names of directors to be appointed are not quantified or disclosed in the filing.